Despite the macroeconomic challenges, the biotech industry is primed for long-term growth. An aging population and the need for quality treatments for rare and common diseases underpins this positive outlook.
Therefore, it could be wise to invest in these fundamentally strong biotech stocks…
This post appeared first on Option Sensei.